Metraipolis › archive › dc_b9fd4388ceda

Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for… — Europe PMC PMID:41035633

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41035633
DOI
10.3389/fimmu.2025.1654573
License (as archived)
solo-consultazione
Archived
2026-11-09T22:03:22.449Z
SHA-256 of the archived text
7d7fd66cfada2d9a3063ed5ee10fd304099a1ff6dbd9bb45929f80fbc51f14f1
Stable URL of this page
https://metraipolis.com/documento/dc_b9fd4388ceda

How to cite

Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for… — Europe PMC PMID:41035633 — Europe PMC (en), https://europepmc.org/article/MED/41035633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9fd4388ceda (Metraipolis archive dc_b9fd4388ceda, sha256 7d7fd66cfada2d9a3063ed5ee10fd304099a1ff6dbd9bb45929f80fbc51f14f1)
BibTeX
@misc{dcb9fd4388ceda,
  title = {Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for… — Europe PMC PMID:41035633},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41035633},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9fd4388ceda; sha256 7d7fd66cfada2d9a3063ed5ee10fd304099a1ff6dbd9bb45929f80fbc51f14f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41035633. Agents can read the archived copy with the MCP tool read_document.